Results 161 to 170 of about 853,691 (310)

Basel Chemistry Symposium 2014 In Memory of Prof. T. Reichstein

CHIMIA, 2015
Christophe Daeppen, Markus Gantenbein, Michel Rickhaus, Lukas Jundt, Martin Rother, Charlotte Laupheimer, Isabel Kerschgens, Andrea Pannwitz, Daniel Bachmann, Ina Bodoky   +9 more
doaj   +1 more source

Study of C−H⋅⋅⋅π interactions with pyrrole and chelate rings in metal-porphyrin complexes [PDF]

, 2006
The Cambridge Structural Database (CSD) was screened in order to find and investigate specific C−H⋅⋅⋅π interactions between C−H groups and two types of rings with delocalized π-bonds that exist in porphyrin: pyrrole and six-membered chelate.
Bogdanović, Goran A., Medaković, Vesna B., Milčić, Miloš K.   +2 more
core  

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Basel Chemistry Christmas Symposium 2015

CHIMIA, 2016
Andrea Pannwitz, Serena Rigo, Linda Bannwart, Lorenzo Bizzini, Sabine Malzkuhn, Thomas Müntener, Charlotte Laupheimer   +6 more
doaj   +1 more source

Comparison of two views regarding the nature of the X-H…phenyl interaction [PDF]

, 2004
There are two approaches in the analysis of the nature of the X-H…phenyl interactions. One is based on the assumption that atoms, bonds and the π plane belonging to the phenyl ring, are the points which can be involved in the interaction.
Novaković, Slađana B., Tomić, Zoran D., Zarić, Snežana D.   +2 more
core  

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Basel Chemistry Symposium 2013 In Memory of Prof. C. F. Schönbein

CHIMIA, 2013
Patrick Burch, Thomas R. Eaton, Johannes Hoecker, Markus Gantenbein, Lukas Jundt, Michel Rickhaus   +5 more
doaj   +1 more source

High-pressure synthesis of K_{4}N_{6} compound entirely composed of aromatic hexazine [N_{6}]^{4-} anion [PDF]

arXiv
The synthesis of hexazine N_{6} ring is another milestone in nitrogen chemistry after that of aromatic [N_{5}]^{-} anion. However, due to the diversity of carried charges, realizing compounds entirely composed of aromatic hexazine N_{6} ring potentially with high-stability is a challenge.
arxiv  

Synthetic Organic Chemistry Based on Small Ring Compounds

ChemInform, 2007
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
openaire   +5 more sources

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source